JPMorgan reiterates Overweight rating on Heineken stock ahead of Q3 results

JPMorgan maintained its Overweight rating and EUR95.00 price target for Heineken NV, citing an attractive valuation and favorable risk/reward despite revising FY25 volume forecasts downward to -1.7% due to weaker demand and adverse weather. The investment bank expects Heineken to maintain its medium-term organic EBIT growth guidance of +4-8% and potentially raise its free cash flow outlook to EUR3-3.5 billion at its upcoming Capital Markets Day, supported by productivity initiatives and price increases that underpin a maintained +6.1% organic EBIT growth projection.

Analysis

JPMorgan has reiterated its Overweight rating and EUR95.00 price target on Heineken NV, signaling confidence despite near-term operational headwinds. The bank has lowered its FY25 volume forecast to -1.7% from -0.1%, attributing the revision to cyclically weaker demand, adverse weather in Brazil, Mexico, and India, and ongoing weakness in Europe. However, JPMorgan maintains its organic EBIT growth projection for the same period at +6.1%, indicating that the negative volume impact is expected to be fully offset by strong pricing power, productivity initiatives, and robust performance in Vietnam. Looking ahead to the company's Capital Markets Day, the bank anticipates Heineken will affirm its medium-term organic EBIT growth guidance of +4-8% and potentially raise its free cash flow outlook to EUR3-3.5 billion. The investment thesis is underpinned by valuation, with the stock trading at a 12.6x 2026E P/E and 7.6x EV/EBITDA, representing a respective 13% and 20% discount to the sector, which supports the view of a favorable risk/reward profile over the next six months.

Key Decisions for Investors

• Investors could consider the current valuation, which trades at a notable 13-20% discount to peers, as an attractive entry point given the analyst's expectation of a favorable risk/reward dynamic over the next six months.
• It is prudent to be prepared for potential near-term share price volatility ahead of the third-quarter results, as the market may react to the downward revision in volume forecasts for key regions.
• The upcoming Capital Markets Day on October 22-23 should be monitored closely, as a potential upward revision to the free cash flow outlook could serve as a significant positive catalyst for the stock.